The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Using probiotics in children with cystic fibrosis

    The results of this study suggest that probiotics might delay respiratory impairment.

    First, the details.

    • 19 children received both Lactobacillus GG (LGG) for 6 months and an oral rehydration solution for 6 months in random sequence.
    • Neither the patients (caregivers) nor the researchers were told of the treatment.

    And, the results with LGG compared to the rehydration solution.

    • Patients treated with LGG showed a significant reduction in events associated with a worsening of their pulmonary condition.
    • They had significantly fewer admissions to the hospital.
    • There was a significant increase in lung function as measured by the forced expiratory volume at 1 second test (FEV1).
    • And a significant increase in body weight.

    The bottom line?
    The authors concluded, “Probiotics may delay respiratory impairment and … a relationship exists between intestinal and pulmonary inflammation.”

    These results support earlier findings by the same researchers at the University of Naples in Italy where it was concluded that “Intestinal inflammation is a major feature of cystic fibrosis and is reduced by probiotics. The latter finding suggests that intestinal microflora play a major role in intestinal inflammation in cystic fibrosis children.”

    10/3/07 15:30 JR

    Leave a Comment

    You must be logged in to post a comment.